UG Healthcare Corporation Ltd
SGX:8K7
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | EV/FCFF | ||||
---|---|---|---|---|---|
MY |
UG Healthcare Corporation Ltd
SGX:8K7
|
92.3m SGD | -1.1 | ||
CH |
Alcon AG
SIX:ALC
|
41B CHF | 62.5 | ||
JP |
Hoya Corp
TSE:7741
|
6.6T JPY | 35.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
194.5B DKK | 203.1 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19B USD | 29.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 157.4 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.4B CNY | 48.7 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 528.8 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.3B CHF | -128.4 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.7B USD | 25.7 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 25.9 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.